Agios Pharmaceuticals Inc (STU:8AP)
€ 42 2.6 (6.6%) Market Cap: 2.40 Bil Enterprise Value: 1.91 Bil PE Ratio: 0 PB Ratio: 3.45 GF Score: 41/100

Agios Pharmaceuticals Inc Investor Day Transcript

Nov 17, 2021 / 07:00PM GMT
Release Date Price: €36.78 (+4.05%)
Holly Manning
Agios Pharmaceuticals, Inc. - Senior Director of IR

All right. Can everyone see my screen? Great. Well, now that George is safe and sound, we can kick things off. All right. Jackie, you ready, you want me to turn it over to you?

Jacqualyn A. Fouse
Agios Pharmaceuticals, Inc. - CEO & Director

I am ready. George is back in the house. So here we are. Thank you, Holly. Hi, everybody. Thanks for being with us this afternoon. We do appreciate your time for an event that we're very pleased to participate in with you this afternoon. We think we've got some interesting things to talk about, and we hope that you're going to be excited about what we're seeing, that we're excited about. And I want to thank all my panelists in advance for joining us today. I think we've got a great agenda, and maybe Holly will just click to the next slide, please.

Forward-looking statements that you're all very familiar with. Thank you.

So here's our agenda today. I will be pretty brief with my opening remarks, and I'm going to turn it over to Charlie

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot